ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1987

CCN3 Regulates Macrophage Function in MSU-induced Inflammation

Lihua Duan1, Jie Chen 1 and Jixin Zhong 2, 1Department of Rheumatology and Clinical Immunology, Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, China (People's Republic), 2Cardiovascular Research Institute, School of Medicine, Case Western Reserve University, Cleveland, OH

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: CCN3, gout, inflammasome activation and IL-1, Macrophage

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Gout is the most common metabolic disease in which monosodium urate (MSU) crystals form and deposit in the joints and soft tissues of patients. While several lines of evidence support the importance of MSU-induced macrophage activation in the inflammatory response in gout, the mechanism remains unclear. Recent studies implicate CCN3 matricellular signaling protein as emerging player in the regulation of inflammation, reactive oxygen species production and angiogenesis. Additional data suggest that CCN3 regulates macrophage polarization and foam cell formation in diabetes and atherosclerosis. However, information regarding the role of CCN3 in gout remains unclear. Therefore, the objective of this investigation was to decipher the role of CCN3 in the pathogenesis of gout.

Methods: A total of 41 gout patients and 41 healthy control subjects, matched for age and sex ratio, were enrolled. PBMCs and serum were harvested and subjected to real-time PCR and ELISA analysis. MSU-induced peritonitis was conducted in LysM-Cre CCN3fl/fl mice with a macrophage-selective deletion of CCN3. In addition, the IL-1β production of bone marrow derived macrophage (BMM) and peritoneal macrophage with CCN3 deletion or not were investigated.

Results: Levels of CCN3 were predominantly increased in gout patients when compared to healthy controls. Furthermore, the sera CCN3 levels showed a positive correlation with inflammatory response protein CRP, while no significant correlation with lipids level were observed. To further address the role CCN3 in the pathogenesis of gout, MSU-induced peritonitis was conducted in LysM-Cre CCN3fl/fl mice with a macrophage-selective deletion of CCN3. As expected, LysM-Cre CCN3fl/fl mice showed a decreased cell infiltration in the peritoneal cavity. In addition, decreased levels of IL-1β in the peritoneal lavage fluid and caspase1 activity in peritoneal macrophage were observed in LysM-Cre CCN3fl/fl mice. Similarly, bone marrow derived macrophage (BMM) and peritoneal macrophage with CCN3 deletion showed an impaired caspase1 activation and IL-1β production in vitro.

Conclusion: These results indicate that CCN3 in macrophage  plays a critical role in the development of MSU-induced inflammation.


Disclosure: L. Duan, None; J. Chen, None; J. Zhong, None.

To cite this abstract in AMA style:

Duan L, Chen J, Zhong J. CCN3 Regulates Macrophage Function in MSU-induced Inflammation [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/ccn3-regulates-macrophage-function-in-msu-induced-inflammation/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ccn3-regulates-macrophage-function-in-msu-induced-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology